| | |  | | | | Record from Web of Science® | | | | | | |
| A PHASE-I TRIAL OF INTRAVENOUSLY-ADMINISTERED RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN CANCER-PATIENTS |
|
|
| Author(s): FEINBERG B, KURZROCK R, TALPAZ M, BLICK M, SAKS S, GUTTERMAN JU |
| Source: JOURNAL OF CLINICAL ONCOLOGY Volume: 6 Issue: 8 Pages: 1328-1334 Published: AUG 1988 |
| Times Cited: 195 References: 23 |
| Document Type: Article |
| Language: English |
Addresses:
1. UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT CLIN IMMUNOL & BIOL THERAPY, BOX 41, HOUSTON, TX 77030 USA
2. GENENTECH INC, SAN FRANCISCO, CA 94080 USA |
| Publisher: W B SAUNDERS CO, INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 |
| Subject Category: Oncology |
| IDS Number: P6294 |
| ISSN: 0732-183X |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |